Interventional Cardiology, 2017 (vol. 16), issue 4

Original articles

Plasma sCD163 levels in patients with ST-elevation myocardial infarction

Radek Pudil, Lucie Horáková, Ctirad Andrýs, Josef Šťásek

Interv Akut Kardiol. 2017;16(4):142-145 | DOI: 10.36290/kar.2017.023  

Background: The ischemia/reperfusion process in the course of acute coronary syndrome with ST-segment elevation is associatedwith significant increase of immune system activation. CD163 molecule belongs to important parts of the scavenger system,which helps to eliminate hemoglobin-haptoglobin complex and has the potential to suppress reactive oxygen radicals production.Aim: The aim of our study was to assess sCD163 level in the course of STEMI.Patients and method: Plasma sDC163 level was assessed in a group of 29 patients (25 males, 4 females) of average age 64.5 let± 7.5 yrs. at the time of admission, at 24 hours and at 96 hours.Results: The...

Review articles

Cardiac implanted electronic device-related infective endocarditis

Jana Bínová, Miloš Kubánek, Kamil Sedláček, Lukáš Krýže, Josef Kautzner

Interv Akut Kardiol. 2017;16(4):146-150 | DOI: 10.36290/kar.2017.021  

The use of cardiac implantable electronic devices has expanded dramatically over the past decade and infective endocarditis ofthese devices (CDRIE) is associated with high morbidity and mortality. 1 year mortality has not improve and remains at 25 %. Riskgroups are mainly older patients with multiple commorbidities. CDRIE occurs most often 6 month after implantation. Staphylococcalpredominate as the causative organism. Diagnosis of disease is not easy, clinical presentation is highly variable. Echocardiographyand blood cultures are the cornerstones of the diagnosis. CDRIE must be treated by prolonged antibiotic therapy and frequentlyrequires complete...

Case reports

A rare cause of acute myocardial infarction in a 20-year-old patient diagnosed with severe ketoacidosis

František Nehaj, Michal Mokáň, Juraj Sokol, Ľudovít Šutarík, František Kovář, Martin Janík, Marianna Kubašková, Peter Galajda, Marián Mokáň

Interv Akut Kardiol. 2017;16(4):152-155 | DOI: 10.36290/kar.2017.015  

Cardiovascular diseases are the most common cause of the mortality in developed countries. The coronary artery disease is onthe first place as a cause of a death what represent seven million people every year and 12.8 % from all deaths in the world. Everysixth man and every seventh woman die of myocardial infarction (MI). Diabetes mellitus (DM) belongs to the most commonchronic diseases and cardiovascular diseases occur with this diagnose 4–8 times more often. The acute complications of DM arecaused by sudden metabolic decompensation, which can directly threaten the life of the patient. We present a case report of 20years old woman with juvenile...

Acute coronary syndrom as a rare trigger of Tako-tsubo cardiomyopathy

Lucia Sabolová

Interv Akut Kardiol. 2017;16(4):156-157 | DOI: 10.36290/kar.2017.022  

Stress cardiomyopathy and myocardial infarction are generally regarded as mutually exclusive diagnoses. We report cases oftwo women with acute chest pain. Their echocardiogram and ventriculography were typical of stress cardiomyopathy, but alsothey had one acute occlusive or subocclusive coronary lesion and a highly significant rise in troponin (non typical for Tako-tsubocardiomyopathy). This is a rare case of concomitant myocardial infarction and stress cardiomyopathy, in which the acute coronarysyndrome itself may have been the stressor, given the absence of other identifiable causes.

Pharmacotherapy

Evolocumab for the treatment of familial hypercholesterolemia

Vladimír Bláha

Interv Akut Kardiol. 2017;16(4):158-164  

Familial hypercholesterolaemia (FH) is the most common dominantly inherited monogenic disorder in human beings worldwide.Familial hypercholesterolaemia is caused by mutations in genes encoding key proteins involved in low density lipoproteincholesterol (LDL-C) metabolism, which leads to reduced cellular uptake of LDL cholesterol, increased plasma LDL cholesterolconcentrations, and premature development of cardiovascular disease. Despite the availability of reliable diagnostic criteria (highLDL-C levels, family history or premature CHD and hypercholesterolemia, cerebral/peripheral vascular disease, and the presenceof tendon xanthomata or presence of...

Information

Nová cílená aktualizace pro protidestičkovou léčbu na ESC 2017 Barcelona

Jan F. Vojáček

Interv Akut Kardiol. 2017;16(4):166-169  


Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.